Scleroderma is an autoimmune disease that mainly affects the skin of the hands. Stem Cell therapy for Scleroderma is an optimal treatment option and is supported by many scientific researches as well.
Scleroderma can affect various tissues and organs in the body.
Scleroderma is an autoimmune disease where the body cells start attacking other cells in the body. The stem cells, especially the hematopoietic stem cells (HSCT) can halt the scleroderma progression in patients.
According to a study published in January 2018, patients with scleroderma achieved long-term event-free survival with stem-cell transplantation as compared to standard of care therapy.
The stem cells used can be either autologous (extracted from the patient’s body) or allogenic (taken from a matched donor). These stem cells can be administered in three of the mentioned ways:
For more information on stem cell therapy for Scleroderma in Mexico, feel free to contact our team. Book your appointments today.
1. The New England Journal of Medicine: Myeloablative Autologous Stem Cell Transplantation for Severe Scleroderma
*Please review our full disclaimers, Terms & Conditions and, Health Privacy & Confidentiality Statement. Individual results may vary. The statements on this website have not been evaluated by the FDA or any medical professional.